Correlation Between Beta Drugs and AVALON TECHNOLOGIES

Can any of the company-specific risk be diversified away by investing in both Beta Drugs and AVALON TECHNOLOGIES at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and AVALON TECHNOLOGIES into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Beta Drugs and AVALON TECHNOLOGIES LTD, you can compare the effects of market volatilities on Beta Drugs and AVALON TECHNOLOGIES and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of AVALON TECHNOLOGIES. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and AVALON TECHNOLOGIES.

Diversification Opportunities for Beta Drugs and AVALON TECHNOLOGIES

0.77

Correlation Coefficient

Beta Drugs  AVALON TECHNOLOGIES

Poor diversification

The 3 months correlation between Beta and AVALON is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and AVALON TECHNOLOGIES LTD in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AVALON TECHNOLOGIES LTD and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with AVALON TECHNOLOGIES. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AVALON TECHNOLOGIES LTD has no effect on the direction of Beta Drugs i.e., Beta Drugs and AVALON TECHNOLOGIES go up and down completely randomly.

Pair Corralation between Beta Drugs and AVALON TECHNOLOGIES

Assuming the 90 days trading horizon Beta Drugs is expected to under-perform the AVALON TECHNOLOGIES. But the stock apears to be less risky and, when comparing its historical volatility, Beta Drugs is 1.43 times less risky than AVALON TECHNOLOGIES. The stock trades about -0.21 of its potential returns per unit of risk. The AVALON TECHNOLOGIES LTD is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  86,000  in AVALON TECHNOLOGIES LTD on October 9, 2024 and sell it today you would earn a total of  6,030  from holding AVALON TECHNOLOGIES LTD or generate 7.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Beta Drugs  vs.  AVALON TECHNOLOGIES LTD

Beta Drugs

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.

AVALON TECHNOLOGIES LTD

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in AVALON TECHNOLOGIES LTD are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile essential indicators, AVALON TECHNOLOGIES sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Beta Drugs and AVALON TECHNOLOGIES

The main advantage of trading using opposite Beta Drugs and AVALON TECHNOLOGIES positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, AVALON TECHNOLOGIES can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVALON TECHNOLOGIES will offset losses from the drop in AVALON TECHNOLOGIES's long position.

The idea behind Beta Drugs and AVALON TECHNOLOGIES LTD pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.